BioNTech Misses Q1 Earnings, Revenue on Lower COVID-19 Sales

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 6, 2024 at 11:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,332
    Likes Received:
    3
    via BioNTech’s total revenue in the first quarter of 2024 nosedived to around $202 million, a sharp decline from nearly $1.38 billion during the same time period last year, the German biotech reported on Monday.

    article source